(Reuters) – Britain’s medicines regulator said on Thursday it had approved the use of Moderna Inc’s COVID-19 vaccine in children between the ages of six and 11 years.
(Reporting by Pushkala Aripaka in Bengaluru; Editing by Shailesh Kuber)
(Reuters) – Britain’s medicines regulator said on Thursday it had approved the use of Moderna Inc’s COVID-19 vaccine in children between the ages of six and 11 years.
(Reporting by Pushkala Aripaka in Bengaluru; Editing by Shailesh Kuber)
